iShares MSCI UK UCITS ETF Fundamental Analysis
iShares MSCI UK UCITS ETF (CSUK.SW) shows weak financial fundamentals with a PE ratio of 11.92, profit margin of 0.00%, and ROE of 0.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 25.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CSUK.SW's fundamental strength across five key dimensions:
Efficiency Score
WeakCSUK.SW struggles to generate sufficient returns from assets.
Valuation Score
ModerateCSUK.SW shows balanced valuation metrics.
Growth Score
ModerateCSUK.SW shows steady but slowing expansion.
Financial Health Score
ModerateCSUK.SW shows balanced financial health with some risks.
Profitability Score
WeakCSUK.SW struggles to sustain strong margins.
Key Financial Metrics
Is CSUK.SW Expensive or Cheap?
P/E Ratio
CSUK.SW trades at 11.92 times earnings. This suggests potential undervaluation.
Debt/Equity
iShares MSCI UK UCITS ETF has a debt-to-equity ratio of 0.00, indicating its leverage.
How Well Does CSUK.SW Make Money?
Net Profit Margin
For every $100 in sales, iShares MSCI UK UCITS ETF keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.00 in profit for every $100 of shareholder equity.
ROA
iShares MSCI UK UCITS ETF generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How CSUK.SW Stacks Against Its Sector Peers
| Metric | CSUK.SW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 20.79 | N/A |
| ROE | 0.00% | 622.00% | Weak |
| Net Margin | 0.00% | -1174.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 1.51 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 935.58 | Weak Liquidity |
| ROA | 0.00% | -788.00% (disorted) | Weak |
CSUK.SW outperforms its industry in 1 out of 5 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews iShares MSCI UK UCITS ETF's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical